Moreover, data are lacking about the relationship between impaired circulating fetuin-A and RBP4 production and the markers of obesity-related dyslipidemia (i.e., small HDL, mean LDL size etc.)in a special morbidly obese but non-diabetic population. The gene discussed is AHSG; the disease is metabolic syndrome.